IBTK and myeloid sarcoma: We demonstrate that mitochondrial respiratory chain mutations in humans result in corresponding phenotypic and functional changes of their B cells in vivo and show that BTKi (or inhibition of respiration) can essentially abrogate the abnormal proinflammatory profile of untreated MS patient B cells ex vivo.